Medela Potentia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 269K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 17.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (269K versus 96.7K). Which is the better fit depends on your goals.
| MDLA | OBAT | |
|---|---|---|
Market Cap | 2.89T | 167.37B |
Volume | 269K | 96.7K |
Lot | 2.69K | 967 |
Turnover | 55.76M | 23.82M |
Average Price | 207.28 | 246.34 |
Value | 55.76M | 23.82M |
Indicative Equilibrium Price | 208 | 248 |
Indicative Equilibrium Volume | 15 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →